PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+13.82%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.46B
AUM Growth
+$2.46B
(-4%)
Cap. Flow
-$342M
Cap. Flow
% of AUM
-13.91%
Top 10 Holdings %
Top 10 Hldgs %
59.49%
Holding
158
New
14
Increased
43
Reduced
54
Closed
16
Top Buys
| 1 |
Ball Corp
BALL
|
$31.9M |
| 2 |
TransUnion
TRU
|
$13.6M |
| 3 |
Visa
V
|
$7.21M |
| 4 |
Baxter International
BAX
|
$6.57M |
| 5 |
Monster Beverage
MNST
|
$4M |
Top Sells
| 1 |
Microchip Technology
MCHP
|
$126M |
| 2 |
Carlisle Companies
CSL
|
$83.9M |
| 3 |
NXP Semiconductors
NXPI
|
$69.5M |
| 4 |
Pinduoduo
PDD
|
$32.1M |
| 5 |
RH
RH
|
$25.2M |
Sector Composition
| 1 | Consumer Discretionary | 20.74% |
| 2 | Energy | 15.66% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 14.09% |
| 5 | Technology | 13.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
26
Block, Inc.
XYZ
$46.2B
| $21.3M | 0.86% |
275,040
+13,549
| +5% | +$1.05M |
|
27
Iris Energy
IREN
$7.67B
| $18.1M | 0.73% |
2,527,367
-79,705
| -3% | -$570K |
|
28
JD.com
JD
$44.2B
| $15.8M | 0.64% |
546,343
-1,000
| -0.2% | -$28.9K |
|
29
DoorDash
DASH
$106B
| $15.2M | 0.62% |
154,040
-42,810
| -22% | -$4.23M |
|
30
Quanterix
QTRX
$202M
| $14M | 0.57% |
510,753
-148,715
| -23% | -$4.07M |
|
|
DDL
31
Dingdong
DDL
$449M
| $14M | 0.57% |
9,308,945
+166,736
| +2% | +$250K |
|
|
RYZB
32
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $13.8M | 0.56% |
222,222
| – | – |
|
33
Booking.com
BKNG
$181B
| $12.2M | 0.49% |
3,426
-538
| -14% | -$1.91M |
|
34
Huazhu Hotels Group
HTHT
$11.2B
| $11.5M | 0.47% |
343,130
-2,104
| -0.6% | -$70.4K |
|
35
Alphabet (Google) Class A
GOOGL
$2.79T
| $10.6M | 0.43% |
75,615
-23,212
| -23% | -$3.24M |
|
36
Adobe
ADBE
$148B
| $10.3M | 0.42% |
17,320
+1,926
| +13% | +$1.15M |
|
37
Lam Research
LRCX
$124B
| $10M | 0.41% |
127,960
-3,140
| -2% | -$246K |
|
38
Planet Fitness
PLNT
$8.55B
| $9.92M | 0.4% |
135,861
-31,824
| -19% | -$2.32M |
|
39
Microsoft
MSFT
$3.76T
| $9.77M | 0.4% |
25,989
+5,253
| +25% | +$1.98M |
|
40
Immunovant
IMVT
$2.91B
| $9.64M | 0.39% |
228,765
+2,826
| +1% | +$119K |
|
41
908 Devices
MASS
$199M
| $8.77M | 0.36% |
781,871
-52,953
| -6% | -$594K |
|
42
Esperion Therapeutics
ESPR
$490M
| $8.4M | 0.34% |
2,810,555
-378,962
| -12% | -$1.13M |
|
43
BioNTech
BNTX
$24.1B
| $8.4M | 0.34% |
79,552
+11,214
| +16% | +$1.18M |
|
44
Moderna
MRNA
$9.36B
| $8.08M | 0.33% |
81,252
-84
| -0.1% | -$8.35K |
|
45
Apogee Therapeutics
APGE
$2.27B
| $7.93M | 0.32% |
283,683
| – | – |
|
46
AC Immune
ACIU
$227M
| $7.58M | 0.31% |
1,515,585
+193,123
| +15% | +$966K |
|
47
Roivant Sciences
ROIV
$8.6B
| $7.51M | 0.31% |
669,047
+70,315
| +12% | +$790K |
|
|
48
Visa
V
$681B
| $7.21M | 0.29% |
+27,693
| New | +$7.21M |
|
49
Johnson & Johnson
JNJ
$429B
| $6.68M | 0.27% |
42,647
| – | – |
|
|
BCYC
50
Bicycle Therapeutics
BCYC
$492M
| $6.55M | 0.27% |
362,080
+76,601
| +27% | +$1.38M |
|